Craig Boerner Archive — Page 16 of 20
-
December 12, 2013
Otolaryngology lands performance excellence award
The Tennessee Center for Performance Excellence (TNCPE) is awarding Vanderbilt Bill Wilkerson Center’s Department of Otolaryngology with its Commitment Award in the annual Excellence in Tennessee recognition program. -
December 9, 2013
Penicillin equally effective as ‘big gun’ antibiotics for treating less severe childhood pneumonia, Vanderbilt study shows
Children hospitalized for pneumonia have similar outcomes, including length of stay and costs, regardless of whether they are treated with “big gun” antibiotics such as ceftriaxone or cefotaxime or more narrowly focused antibiotics such as ampicillin or penicillin. -
December 5, 2013
First-ever study uses EMRs to spot new disease associations
Vanderbilt University Medical Center researchers and co-authors from four other U.S. institutions from the Electronic Medical Records and Genomics (eMERGE) Network are repurposing genetic data and electronic medical records to perform the first large-scale phenome-wide association study (PheWAS), released today in Nature Biotechnology. -
November 14, 2013
Immunosuppressive drugs unlikely to raise fetal risk: study
Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism. -
October 31, 2013
Knowing who their physician is boosts patient satisfaction
Knowing who your doctor is — and a couple of facts about that person — may go a long way toward improving patient satisfaction, according to a Vanderbilt study in the Journal of Orthopaedic Trauma. -
October 3, 2013
Study finds cognitive deficits common after critical illness
Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine.